Overall survival is the primary endpoint in a trial of neoadjuvant chemotherapy for bladder cancer

Edward L. Korn, Boris Freidlin, Jeffrey S. Abrams, Susan Halabi, Design Issues in Randomized Phase II/III Trials Journal of Clinical Oncology. ,vol. 30, pp. 667- 671 ,(2012) , 10.1200/JCO.2011.38.5732

H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V.O. Speights, Nicholas J. Vogelzang, Donald L. Trump, Ralph W. deVere White, Michael F. Sarosdy, David P. Wood, Derek Raghavan, E. David Crawford, Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer The New England Journal of Medicine. ,vol. 349, pp. 859- 866 ,(2003) , 10.1056/NEJMOA022148

Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René HM Verheijen, Maria EL Van Der Burg, Angel J Lacave, Pierluigi Benedetti Panici, Gemma G Kenter, Antonio Casado, Cesar Mendiola, Corneel Coens, Leen Verleye, Gavin CE Stuart, Sergio Pecorelli, Nick S Reed, None, Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer The New England Journal of Medicine. ,vol. 363, pp. 943- 953 ,(2010) , 10.1056/NEJMOA0908806

Christopher Logothetis, David Swanson, Robert Amato, Marie Banks, Laury Finn, Alberto Ayala, Jae Ro, Richard Babaian, Colin Dinney, Julie Ellerhorst, Craig Hall, Andrew Von Eschenbach, Optimal Delivery of Perioperative Chemotherapy: Preliminary Results of a Randomized, Prospective, Comparative Trial of Preoperative and Postoperative Chemotherapy for Invasive Bladder Carcinoma The Journal of Urology. ,vol. 155, pp. 1241- 1245 ,(1996) , 10.1016/S0022-5347(01)66230-X

Harras B. Zaid, Sanjay G. Patel, C.J. Stimson, Matthew J. Resnick, Michael S. Cookson, Daniel A. Barocas, Sam S. Chang, Trends in the Utilization of Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Results From the National Cancer Database Urology. ,vol. 83, pp. 75- 80 ,(2014) , 10.1016/J.UROLOGY.2013.07.072

Cora N Sternberg, Iwona Skoneczna, J Martijn Kerst, Peter Albers, Sophie D Fossa, Mads Agerbaek, Herlinde Dumez, Maria de Santis, Christine Théodore, Michael G Leahy, John D Chester, Antony Verbaeys, Gedske Daugaard, Lori Wood, J Alfred Witjes, Ronald de Wit, Lionel Geoffrois, Lisa Sengelov, George Thalmann, Danielle Charpentier, Frédéric Rolland, Laurent Mignot, Santhanam Sundar, Paul Symonds, John Graham, Florence Joly, Sandrine Marreaud, Laurence Collette, Richard Sylvester, Groupe d'Etude des Tumeurs Urogénitales, National Cancer Research Institute Bladder Cancer Study Group, National Cancer Institute of Canada Clinical Trials Group, Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial Lancet Oncology. ,vol. 16, pp. 76- 86 ,(2015) , 10.1016/S1470-2045(14)71160-X

Peter Albers, Roswitha Siener, Susanne Krege, Hans-Uwe Schmelz, Klaus-Peter Dieckmann, Axel Heidenreich, Peter Kwasny, Maik Pechoel, Jan Lehmann, Sabine Kliesch, Kai-Uwe Köhrmann, Rolf Fimmers, Lothar Weiβbach, Volker Loy, Christian Wittekind, Michael Hartmann, Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course of Bleomycin and Etoposide Plus Cisplatin Chemotherapy in the Adjuvant Treatment of Clinical Stage I Nonseminomatous Testicular Germ Cell Tumors: AUO Trial AH 01/94 by the German Testicular Cancer Study Group Journal of Clinical Oncology. ,vol. 26, pp. 2966- 2972 ,(2008) , 10.1200/JCO.2007.12.0899

Lawrence V. Rubinstein, Edward L. Korn, Boris Freidlin, Sally Hunsberger, S. Percy Ivy, Malcolm A. Smith, Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials Journal of Clinical Oncology. ,vol. 23, pp. 7199- 7206 ,(2005) , 10.1200/JCO.2005.01.149

Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas, Stephen Dobbs, Sharadah Essapen, Jeremy Twigg, Jonathan Herod, Glenn McCluggage, Mahesh Parmar, Ann-Marie Swart, Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial The Lancet. ,vol. 386, pp. 249- 257 ,(2015) , 10.1016/S0140-6736(14)62223-6

Chemotherapy for bladder cancer. The New England Journal of Medicine. ,vol. 349, pp. 2272- ,(2003) , 10.1056/NEJM200312043492323